MHPSY yields 25.01% · JNJ yields 2.13%● Live data
📍 JNJ pulled ahead of the other in Year 9
Combined, MHPSY + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of MHPSY + JNJ for your $10,000?
MHP SE, together with its subsidiaries, produces and sells food and poultry products in Ukraine and internationally. It operates in four segments: Poultry & Related Operations, Grain Growing Operations, Meat-Processing & Other Agricultural Operations, and European Operating. The Poultry & Related Operations segment produces and sells fresh and frozen chicken meats, vegetable oils, including sunflower and soybean, as well as mixed fodder under the brand Nasha Riaba, Apetytna, Baschinsky, Vinnytski Kurchata, Kurator, Sultanah, Assilah, Al-Hassanat, Home Style Chicken, Ukrainian Chicken, and Chef's Secrets names to export markets. The company's Grain Growing Operations segment grows crops for fodder production and sale to third parties. Its Meat-Processing & Other Agricultural Operations segment produces and sells sausages, processed and cooked meats, convenience foods, and produce from cattle and diary operations under the Bashchinsky, Lehko!,Qualiko, Skott Smeat, and Sytni brands. The European Operating segment engages in the production and sale of chicken meat and processed poultry meat products under the PP and Poli brands. It is also involved in hatching eggs; and growing of corn, sunflower, and soybean seeds, as well as rape and wheat grains to third parties. MHP SE was founded in 1998 and is headquartered in Kiev, Ukraine.
Full MHPSY Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.